rs 8359 has been researched along with nadp in 1 studies
Studies (rs 8359) | Trials (rs 8359) | Recent Studies (post-2010) (rs 8359) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
---|---|---|---|---|---|
24 | 4 | 1 | 21,608 | 25 | 3,484 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asakawa, T; Endo, A; Hoshino, K; Itoh, K; Kosaka, T; Noji, C; Tanaka, Y; Yamakami, K | 1 |
1 other study(ies) available for rs 8359 and nadp
Article | Year |
---|---|
Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); Administration, Oral; Alcohols; Animals; Chromatography, Liquid; Cytosol; Electrophoresis, Polyacrylamide Gel; Liver; Male; Microsomes, Liver; Molecular Structure; Monoamine Oxidase Inhibitors; NAD; NADP; Nanotechnology; Nitriles; Oxidation-Reduction; Pyrimidines; Rats; Rats, Wistar; Stereoisomerism; Subcellular Fractions; Substrate Specificity; Tandem Mass Spectrometry | 2006 |